TABLE 6.
Deferred N = 179 | Performed N = 75 | Against FFR N = 23 | P-value | |
VOCE | 10 (5.6%) | 7 (9.3%) | 3 (13.0%) | 0.305 |
Death | 5 (2.8%) | 3 (4.0%) | 0 (0.0%) | 0.600 |
Non-fatal MI | 1 (0.6%) | 0 (0.0%) | 0 (0.0%) | 0.760 |
TVR | 6 (3.4%) | 4 (5.3%) | 3 (13.0%) | 0.112 |
VOCE, vessel-oriented composite endpoint; MI, myocardial infarction; TVR, target vessel revascularization.